South Wales, May 1 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "R1TX" on April 16. The details about the trademark application no. UK00004373999 published in the journal no. 2026/018 (May 1).
With CMS Cameron McKenna Nabarro Olswang LLP as representative, R1 Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals; medical preparations and substances; Pharmaceutical preparations for the treatment of neurological, immunological, nephrological, oncological, infectious, cardiovascular, vascular, central and peripheral nervous system, autoimmune, endocrinological, gastrointestinal, genetic, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, ocular, neuromuscular, and viral diseases, conditions and disorders.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004373999
Disclaimer: Curated by HT Syndication.
